Back to Search
Start Over
Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication.
- Source :
-
Journal of Clinical Medicine . Mar2022, Vol. 11 Issue 5, p1234. 1p. - Publication Year :
- 2022
-
Abstract
- Post-SARS-CoV-2 telogen effluvium has been described in case reports of COVID-19 patients. We evaluated the prevalence of post-SARS-CoV-2 telogen effluvium in patients from a single medical center, exploring any causal links with the infection. Our hospital-based, cross-sectional study was conducted with patient participants discharged with a diagnosis of SARS-CoV-2 pneumonia from 1 March to 4 April 2020. All patients were evaluated by the same senior dermatologist; a clinical/dermatoscopic evaluation was performed. Alopecia was assessed in 31.3% of patients, with a significant difference in sex (females 73%, males 26.7%). The average time detected from the onset of the first symptoms to alopecia was 68.43 days. Overall, there were no significant associations between alopecia and COVID-19-related features (length of hospitalization, virologic positivity, or duration of fever), treatment characteristics, or laboratory findings. In this paper, we report that post-infection acute telogen effluvium occurs in a significant number of COVID-19 patients. The burden of this condition may impair the quality of life, with a significant impact on individuals. [ABSTRACT FROM AUTHOR]
- Subjects :
- *COVID-19
*HOSPITAL admission & discharge
*COVID-19 pandemic
*SARS-CoV-2
*BALDNESS
Subjects
Details
- Language :
- English
- ISSN :
- 20770383
- Volume :
- 11
- Issue :
- 5
- Database :
- Academic Search Index
- Journal :
- Journal of Clinical Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 155706511
- Full Text :
- https://doi.org/10.3390/jcm11051234